Valion Bio, Inc. (VBIO)
Nasdaq: VBIO · Electromedical & Electrotherapeutic Apparatus · San Antonio, TX · filing with the SEC since 2019
Filings
329 filings since 2017 beside 76 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 16, 2026.
Filings a yearinsider forms included
14436705810195
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 15 times in the last 36 months, the newest Nov 5, 2026.Listing warning from its exchange (8-K item 3.01): 3 times in the last 36 months, the newest Mar 20, 2026.SEC letters: 24 in the last 36 months, the newest Apr 13, 2026.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 9, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Nov 6, 2026
Nov 2, 2026
8-K items 5.02, 8.01, 9.01
Officer or director change; Other event · Current report
Oct 27, 2026
Oct 27, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Oct 26, 2026
Oct 8, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Oct 7, 2026
Sep 23, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current report
Sep 17, 2026
Sep 1, 2026
8-K items 1.01, 3.02, 5.02, 7.01, 9.01
Major agreement signed; Shares sold without registration; Officer or director change; Investor disclosure (Regulation FD) · Current report
Aug 27, 2026
Aug 27, 2026
8-K items 3.03, 5.03, 7.01, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Aug 26, 2026
Aug 17, 2026
8-K items 3.02, 5.02, 5.07, 8.01, 9.01
Shares sold without registration; Officer or director change; Shareholder vote; Other event · Current report
Aug 14, 2026
Aug 6, 2026
8-K items 1.01, 3.02, 8.01
Major agreement signed; Shares sold without registration; Other event · Current report
Jul 31, 2026
40 of 329 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.